B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia (Q33878649)

29 July 2017

B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia (English)

1 reference

chronic lymphocytic leukemia

29 July 2017

0 references

1 reference

1 reference

8

1 reference

29 July 2017

6

Ulrike Bacher

1 reference

29 July 2017

10

Renata Pasqualini

1 reference

29 July 2017

11

Wadih Arap

1 reference

29 July 2017

Mascha Binder

1

1 reference

29 July 2017

Fabian Müller

2

1 reference

29 July 2017

Antje Jackst

3

1 reference

29 July 2017

Barbara Léchenne

4

1 reference

29 July 2017

Milena Pantic

5

1 reference

29 July 2017

Christine Zu Eulenburg

7

1 reference

29 July 2017

Roland Mertelsmann

9

1 reference

29 July 2017

Martin Trepel

12

1 reference

29 July 2017

language of work or name

English

0 references

publication date

29 November 2010

1 reference

29 July 2017

1 reference

29 July 2017

117

1 reference

29 July 2017

9

1 reference

29 July 2017

1891-1900

1 reference

B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

The immunoglobulin genes: structure and specificity in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Multiple distinct sets of stereotyped antigen receptors indicate a role for antigen in promoting chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

B-cell chronic lymphocytic leukemia, a clonal disease of B lymphocytes with receptors that vary in specificity for (auto)antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Libraries of peptides and proteins displayed on filamentous phage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

The epitope recognized by rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Identification of their epitope reveals the structural basis for the mechanism of action of the immunosuppressive antibodies basiliximab and daclizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

CD20 mimicry by a mAb rituximab-specific linear peptide: a potential tool for active immunotherapy of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu--a new method of epitope definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Fingerprinting the circulating repertoire of antibodies from cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Surface immunoglobulin on B lymphocytes as a potential target for specific peptide ligands in chronic lymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Cloning of idiotype immunoglobulin genes in B cell lymphomas by anchored PCR and production of individual recombinant idiotype vaccines in Escherichia coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Leukemia-targeting ligands isolated from phage-display peptide libraries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

In vivo phage display and vascular heterogeneity: implications for targeted medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Successful expansion but not complete restriction of tropism of adeno-associated virus by in vivo biopanning of random virus display peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Biopanning and rapid analysis of selective interactive ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Rapid expression cloning of human immunoglobulin Fab fragments for the analysis of antigen specificity of B cell lymphomas and anti-idiotype lymphoma vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

Survival of leukemic B cells promoted by engagement of the antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

inferred from DOI database lookup

7 January 2021

based on heuristic

Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25755

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.25755

1 reference

29 July 2017

1 reference